CNUK has supported cervical cancer diagnostic specialist Zilico in finding a corporate investor in China.

We are now its strategic partner in China for manufacture and distribution of its innovative products.

Zilico was founded in 2006 following a collaboration between the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust to develop a more accurate means of diagnosis for cervical intraepithelial neoplasia (CIN).

Its leading product ZedScan is used alongside colposcopy to provide an objective assessment of the cervical epithelial tissue in real time.